FINANCIAL PRESS RELEASE

Paris, April 27, 2020

Revenue growth for 2019/2020: +6% 

                                                                                                                                                              

Improved EBITDA rate expected for 2019/2020

 

Generix Group, Industrial, Logistics and Retail Ecosystems provider with leading Collaborative SaaS Solutions issued today its revenues for the 2019/2020 fiscal year.

Revenue growth for 2019/2020: +6%

 Quarter ended
March 31		Change12 months ended March 31Change
Unaudited (K€)2020201920202019
SaaS7 9867 8721%32 40228 46014%
Maintenance4 6834 6670%19 19918 8602%
Licenses9151 387-34%3 7154 633-20%
Software revenues13 58413 926-2%55 31651 9536%
Consulting Services6 8346 02014%25 77924 6874%
Revenues20 41819 9462%81 09576 6406%
       

With €81.1 million in revenue, the group recorded 6% organic growth over the past fiscal year driven mainly by its dynamic strategic SaaS business (up 14%). Leading growth areas for the financial year were Russia (+60%) and the Iberian Peninsula (+15%), in line with the company’s international deployment strategy. The share of recurring revenue (SaaS & Maintenance) came to 64% over the past financial year. It is also worth noting that non-contractual recurring business in most of part of Consulting Services contributes also to the revenue resilience in the current context.

While January and February were in line with the dynamics of the third quarter of the financial year, March was impacted by the COVID-19 induced crisis. Hence growth for the fourth quarter of the year came in at 2% supported by the positive trend in Consulting Services (up 14%), especially internationally. The Consulting Services business grew significantly in North America, Portugal, the Benelux and in Russia. The SaaS business grew by 1% given an unfavorable baseline effect (growth of 28% over the same quarter last year). The license business (down 34%) was marked by delayed signings in North America, mainly late in the quarter due to the changing public health context in this region.  

New SaaS contracts for Q4: €1.2 million 

 Quarter ended December 31Var. Q4 2020 vs Q4 201912 months ended March 31Var. 2020 vs 2019
Unaudited (K€)2020201920202019
New SaaS contract signing (ACV*)1 1911 449-18%3 5525 173-31%


*New contracts are expressed in ACV (Annual Contract Value), which emphasizes the average annual complementary revenue to be generated after implementing these contracts.

Generix Group recorded €1.2 million over the last quarter in new SaaS contracts, illustrated by:

  • Continuing deployment in Russia, via the Generix Supply Chain Hub platform, for a major specialist retailer,
  • Delayed signings late in the quarter, especially in Europe, due to COVID-19.

Over the financial year, the Group recorded €3.5 million in new contracts won, ensuring that CMRR* was up by 7.4%.

The Generix Group benefits from its very loyal customer base ensuring that the attrition rate always remains a very low one.

Prospects

In line with our announcement on March 31, 2020, the public health crisis does not impact our financial targets for financial year 2019/2020. On the strength of savings made in variable costs and thanks to closely controlling its cost structure, the Group can confirm the improvement in its Ebitda rate, excluding the impact of the IFRS 16 standard for the financial year 2019/2020.

The Group also maintained on March 31, 2020 and to date, a reassuring cash flow situation and has, for example, triggered the measures made available by its banks to suspend loan repayments so as to be able to face any uncertainties relating to the public health crisis over the next two quarters.

* Monthly recurring revenue after taking into account contracts that are signed but which have not started yet and cancel-lations that have not yet taken effect.


 

Supplemental and non-IFRS Financial Information

Supplemental non-IFRS information (above-mentioned as EBITDA) presented in this press release is subject to inherent limitations. It is not based on any comprehensive set of accounting rules or principles and should not be considered as a substitute for IFRS measurements. Also, the Company’s supplemental non-IFRS financial information may not be comparable to similarly titled non-IFRS measures used by other companies.


 

Next financial press release: June 10, 2020 after the market closes

Publication of results for the 2019/2020 fiscal year

About Generix Group

Generix Group is a Collaborative Supply Chain expert present in 60 countries, thanks to its subsidiaries and network of partners. More than 6,000 companies around the world use its SaaS solutions. The group’s 550 employees provide daily support for such customers as Carrefour, Danone, FM Logistic, Fnac-Darty, Essilor, Ferrero and Geodis in the digital transformation of their Supply Chain.

Its collaborative platform, Generix Supply Chain Hub, helps companies to keep the promises they make to their customers. It combines the capabilities to execute physical flows, digitalize information flows, manage collaborative processes and connect companies to all their partners, in real time.

Generix Supply Chain Hub is aimed at all players in the Supply Chain: manufacturers, third- and fourth-party logistics providers (3PL/4PL) and retailers. 

www.generixgroup.com

Founded in France in 1990, the company is listed on the Eurolist market of Euronext Paris, compartment C (ISIN: FR0010501692). To learn more: www.generixgroup.com

Financial Communication Contacts:
Generix Group – Ludovic Luzza – Chief Financial Officer – Tel.: +33 (0)1 77 45 42 80 – lluzza@generixgroup.com
CM-CIC Market Solutions – Stéphanie Stahr – Tel.: +33 (0)1 53 48 80 57 – stephanie.stahr@cmcic.fr

Attachment

  • EXT-EN-FINA-CP-CA-Q4-2019-2020